Drug Delivery System
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
23
NCT05048498
Pharmacokinetics, Tolerability and Safety of NEX-18a
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 27, 2021
Completion: Feb 10, 2022
NCT05643248
To Assess Safety, Tolerability and PK of NEX-20A, a Subcutaneous Prolonged-release Injection to Healthy Subjects
Phase: Early Phase 1
Start: Nov 28, 2022
Completion: Sep 26, 2023
NCT06439056
Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D
Start: May 27, 2024
Completion: Jul 18, 2025
Loading map...